Geisel School of Medicine Celebrates the Class of 2022
On Saturday morning, May 28, the Geisel School of Medicine’s 99 graduates joyously gathered with family and friends outdoors on Dartmouth’s Class of 1978 Life Sciences Center lawn to celebrate the close of their academic studies and the beginning of their careers as physicians. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 31, 2022 Category: Hospital Management Authors: Susan Green Tags: Education Events News Class Day class of 2022 graduation Source Type: news

A collaborative implementation strategy to increase falls prevention training using the age-friendly health systems approach - Severance JJ, Rivera S, Cho J, Hartos J, Khan A, Knebl J.
Falls in the home and in community environments are the leading cause of injuries and long-term disabilities for the aging population. The purpose of this study was to examine outcomes of a partnership among an academic institution, government agency, comm... (Source: SafetyLit)
Source: SafetyLit - May 30, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Building a community-academic partnership to improve screening for intimate partner violence: integrating advocates in healthcare clinic settings - Schubert EC, Galambos CM, Jerofke-Owen T, Arrington E, Jordan GC, Lodh N, Paquette H, Chelimsky G, Piacentine LB.
AIMS: To develop an innovative community-academic partnership to advance, test and promote intimate partner violence screening and referral protocols by comparing the effect of integrating intimate partner violence advocates versus enhancing medical traini... (Source: SafetyLit)
Source: SafetyLit - May 30, 2022 Category: International Medicine & Public Health Tags: Community-Based Prevention Source Type: news

South Africa: No Casualties Reported in Steve Biko Academic Hospital Fire
[SAnews.gov.za] The Gauteng Health Department says at least 18 people and a corpse have been evacuated at the Steve Biko Academic Hospital (SBAH) after a fire broke out in the early hours of Monday morning. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 30, 2022 Category: African Health Source Type: news

Navigating white academe during crisis: the impact of COVID-19 and racial violence on women of color professionals - Melaku TM, Beeman A.
This article explores how women of color professionals in academic institutions perceive their e... (Source: SafetyLit)
Source: SafetyLit - May 28, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Mental Health Resources, Updated to Include Resources on Coping with Mass Shootings
I received an email today asking for permission* to share last year’s blog post on mental health resources and if there were any updates related to mass shootings. With the help of colleagues in the Region 6 office and across the Network I have done my best to compile resources to help individuals and communities cope in the aftermath of mass shootings. This includes some resources related to specific recent shootings. SAMHSA Mission is to reduce the impact of substance abuse and mental illness on America’s communities. Coping Tips for Traumatic Events and Disasters – SAMHSA Emotional distress can happen before ...
Source: The Cornflower - May 26, 2022 Category: Databases & Libraries Authors: Bobbi Newman Tags: Resource Sharing coping with mass shootings mental health resources Source Type: news

University of Pittsburgh competing for $10B in Department of Defense contracts
Pitt leading academic and industry partners to pursue military health contracts. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 26, 2022 Category: Biotechnology Authors: Patty Tascarella Source Type: news

Reduced growth mindset as a mechanism linking childhood trauma with academic performance and internalizing psychopathology - Lurie LA, Hangen EJ, Rosen ML, Crosnoe R, McLaughlin KA.
BACKGROUND: Despite the high prevalence of childhood adversity and well-documented associations with poor academic achievement and psychopathology, effective, scalable interventions remain largely unavailable. Existing interventions targeting growth mindse... (Source: SafetyLit)
Source: SafetyLit - May 26, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, where Polivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment with Polivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression ¹Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today anno...
Source: Roche Investor Update - May 25, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, where Polivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment with Polivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression ¹Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today anno...
Source: Roche Media News - May 25, 2022 Category: Pharmaceuticals Source Type: news

Roche ’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma
First new treatment option in more than 20 years to show a clinically meaningful improvement in progression-free survival is approved for people with previously untreated diffuse large B-cell lymphoma (DLBCL)Approval is based on pivotal data from the phase III POLARIX study, wherePolivy plus R-CHP significantly improved progression-free survival with comparable safety versus the standard of care, R-CHOPFirst-line treatment withPolivy plus R-CHP has the potential to reduce the burden on patients and healthcare systems, associated with disease progression1Basel, 25 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announce...
Source: Roche Investor Update - May 25, 2022 Category: Pharmaceuticals Source Type: news

Nursing Infection Control Practice Adherence, Related Barriers, and Methods of Intervention
This study aims to evaluate the level of infection control (IC) practice adherence and related barriers among nursing staff at a US academic medical center. Furthermore, it surveys staff to identify interventions to improve adherence with IC practices. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 24, 2022 Category: Consumer Health News Source Type: news

Data at the 2022 ASCO Annual Meeting highlight Roche ’s continued commitment to innovation in oncology and personalised healthcare
Pivotal data onglofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leadinghaematology portfolioFurther studies exploring broad genomic testing to support informed treatment decisions for patients and advance cancer care approaches will be presentedBasel, 24 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Oncol...
Source: Roche Media News - May 24, 2022 Category: Pharmaceuticals Source Type: news

Data at the 2022 ASCO Annual Meeting highlight Roche ’s continued commitment to innovation in oncology and personalised healthcare
Pivotal data on glofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading haematology portfolioFurther studies exploring broad genomic testing to support informed treatment decisions for patients and advance cancer care approaches will be presentedBasel, 24 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Onc...
Source: Roche Media News - May 24, 2022 Category: Pharmaceuticals Source Type: news

Data at the 2022 ASCO Annual Meeting highlight Roche ’s continued commitment to innovation in oncology and personalised healthcare
Pivotal data onglofitamab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, in heavily pre-treated patients with aggressive lymphoma, will be presented as part of our industry-leading haematology portfolioFurther studies exploring broad genomic testing to support informed treatment decisions for patients and advance cancer care approaches will be presentedBasel, 24 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Onco...
Source: Roche Investor Update - May 24, 2022 Category: Pharmaceuticals Source Type: news